You are here

House Republicans Again Fail to Chop Affordable Care Act

Lawmakers fall short on votes to override president’s veto

House Republicans have failed to override President Obama’s veto of their bill gutting major pieces of the Patient Protection and Affordable Care Act (PPACA), according to an article posted on the Politico website.

The House voted 241­–186, falling short of the two-thirds majority needed to override a veto of legislation the GOP views as its blueprint for undoing the law should a Republican win the White House. Republican lawmakers said their repeal bill fulfilled a promise to their base to continue their fight against the PPACA.

“Regardless of the outcome, we have now shown there is a clear path to full repeal without 60 votes in the Senate,” Speaker Paul Ryan said ahead of the vote. “It is also just one in a number of steps we’re taking to hold President Obama accountable for the failures of this law.”

Ryan vowed that House Republicans will offer an alternative to the health law this year—a promise that the GOP leadership has made but failed to keep for six years since the law passed.

In January, Congress approved the PPACA repeal measure through a fast-track budget tool known as reconciliation.

The bill repealed Medicaid expansion, subsidies to purchase insurance on the PPACA exchange, and effectively rolled back the law’s individual and employer mandates. It also eliminated the law’s medical device and Cadillac taxes and blocked federal funding to Planned Parenthood for one year.

Three Republicans, Robert Dold (of Illinois), Richard Hanna, and John Katko (both of New York) voted to let the president’s veto stand.

Source: Politico; February 2, 2016.

Recent Headlines

Study of posted prices finds wild variations and missing data
Potential contamination could lead to supply chain disruptions
Despite older, sicker patients, mortality rate fell by a third in 10 years
Study finds fewer than half of trials followed the law
WHO to meet tomorrow to decide on international public heath emergency declaration
Declining lung cancer mortality helped fuel the progress
Kinase inhibitor targets tumors with a PDGFRA exon 18 mutation
Delayed surgery reduces benefits; premature surgery raises risks
Mortality nearly doubled when patients stopped using their drugs